Sleep and Morning Wellbeing Study
This study is looking at how a powdered sleep supplement might help with sleep and morning wellbeing. You might be able to join if you are between 25 and 59 years old, have a BMI (Body Mass Index) between 18.5 and 29.9, and are currently having trouble with your sleep, such as falling asleep or staying asleep. To be considered successful, the study will look at whether participants feel more relaxed in the evening, have better sleep quality, and feel more vital (energetic) in the morning. The study is currently unclear about its recruitment status.
- Study design
- This is a randomized, controlled clinical study, meaning participants will be assigned by chance to different groups, and one group will receive the active supplement while another might receive a placebo (inactive substance). The study plans to include 300 participants.
- What's involved
- You would take the Sleep Supplement for 30 days and complete questionnaires at specific times throughout the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcomes are measured up to 30 days, which is the duration of the interventional treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
NCT07311434
Sleep and Morning Wellbeing Study
Recruiting
NAAges 22–59InterventionalAthletic Greens International
~300 participants
Updated 2026-02-11 on ClinicalTrials.gov
What's tested:Sleep Supplement
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Evening relaxation, sleep quality, and morning vitality
Measured over Days 1, 3, 7, 14, 30
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Philip Sapp, PhD, MS · PRINCIPAL_INVESTIGATOR · Athletic Greens - AG1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Male or female.
Age 25-59 years.
BMI ≥18.5 and ≤29.9 kg/m².
Currently experiencing issues with sleep quality, falling asleep, staying asleep, or waking during the night.
RU-SATED score ≤17.
Willing and able to follow the study protocol.
Willing to discontinue any other supplements (including nootropics, adaptogens, calming herbs), medications, herbal remedies, or over-the-counter sleep medications (e.g., zolpidem, diphenhydramine, Benadryl, ZzzQuil, Unisom, magnesium or melatonin products) used to assist with sleep during the study.
Agree to limit alcohol intake within approximately 4 hours of bedtime throughout participation.
Agree to limit caffeine intake to ≤400 mg/day (about 3-4 cups of coffee) and avoid ingestion of caffeine-containing products after 2:00 PM during the study period.
Generally healthy and not living with any uncontrolled chronic disease.
Resides in the United States.
Willing to discontinue any restricted products and adhere to all required study assessments.
Exclusion
Diagnosed chronic sleep conditions (e.g., insomnia, narcolepsy, REM Behavior Disorder, moderate to severe restless leg syndrome, sleep apnea).
Current use of sleep-tracking technology (e.g., wrist-worn trackers, rings, smartphone apps) that could influence sleep behavior or perception.
Use of hormone therapy (estrogen, progesterone, phytoestrogens) within the last 3 months.
Diagnosed psychiatric disorders including major depressive disorder with acute symptoms, bipolar disorder, generalized anxiety disorder with active symptoms, and PTSD with frequent nightmares.
Diagnosed neurodegenerative or chronic pain disorders, including Parkinson's disease, Alzheimer's disease, or uncontrolled fibromyalgia.
Regular prescribed stimulant use (e.g., amphetamines such as Adderall/Vyvanse; methylphenidate such as Ritalin/Concerta; modafinil/armodafinil).
Current use of CNS-activating antidepressants (bupropion, fluoxetine, venlafaxine, sertraline).
Current or recent use of cannabis or THC-containing products (recreational or medicinal marijuana, CBD with measurable THC, synthetic cannabinoids) within the past 30 days.
Employment in jobs disrupting nighttime sleep (e.g., night shift, rotating shift, excessive travel).
Current use of prescription sleep aids.
Introduction of any new sleep-related supplements, medications, herbal remedies, or melatonin products during the study.
Use of any prescription or OTC products with sedative properties (e.g., melatonin, diphenhydramine, doxylamine, valerian, ZzzQuil, Advil PM) within 4 weeks prior to enrollment or habitual use ≥3 times per week prior to enrollment unless investigator-approved.
Allergy or sensitivity to any study product ingredients.
Pregnant, breastfeeding, or trying to conceive during the study period.
History of substance abuse.
Heavy alcohol use (≥8 drinks/week for women or ≥15 drinks/week for men).
Participation in another research study now or within the next 7 weeks.
Any condition or behavior that, in the investigator's judgment, may interfere with study participation or data integrity.
What this trial measures
- Evening relaxation, sleep quality, and morning vitalityDays 1, 3, 7, 14, 30
Assessed by subjective questionnaire